echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > It's hard for the medical representative to visit.

    It's hard for the medical representative to visit.

    • Last Update: 2020-08-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The new policy was issued, focusing on the inspection of medical institutions outpatient, inpatient departments, pharmacies and other areas of the emergence of medical representatives and other violations of the sale of drugs, medical equipment to medical personnel, business negotiations - the pharmaceutical representatives to visit difficult.
    medical representatives, the visit difficult July 24, the National Health and Care Commission Office issued "on the issuance of 2020 medical industry style construction of the special action plan" (hereinafter referred to as "Notice").
    "Notice" clearly, from July this year to the end of the year, will focus on the treatment of medical personnel to collect kickbacks, pharmaceutical companies illegal marketing behavior: including the investigation and prosecution of medical institutions and practitioners to use the practice of obtaining improper benefits, receiving kickbacks;
    Since August 2020, the Health and Welling Council has entered a phase of centralized publicity and rectification;
    for example, recently, a well-known junior a", "on the prohibition of the door (urgent) consultation area to receive medical representatives notice", because some medical representatives ignore the signs prohibited from entering, gathered at the door of multiple clinics, serious violations of relevant regulations, affecting the hospital order and environment, and easy to trigger the dissatisfaction of outpatient patients and complaints, please outpatient doctors refused to receive and advised.
    from the date of this notice, once verified, the pharmaceutical representatives who violate this provision will be handled by the relevant functional departments (pharmacy, procurement, medical equipment, etc.) in accordance with the relevant system smanagement of the hospital suppliers.
    is understood that the hospital is a medical, teaching, scientific research, prevention, nuclear emergency as one of the three-level A hospital, the hospital has 32 clinical departments, 8 medical and technical departments, functional departments 20.
    2.46 million emergency visits, 926,000 discharges and 42,000 hospitalizations in 2019.
    in fact, this is not new, with marketing compliance and pharmaceutical anti-commercial bribery has become the focus of attention in recent years, many hospitals have issued regulations to strictly limit the activities of medical representatives.
    at present, Guangxi, Shanghai, Tianjin, Beijing and so on have been issued on the medical representatives of the regulatory documents.
    in this regard, Beijing Baocheng Puji Consulting Co. , Ltd. chief consultant Sun Yuewu admitted: This provision has been a long time, on the one hand, to eliminate non-academic behavior between representatives and doctors, but also to take into account the medical representatives in outpatient and emergency and doctor communication, may affect the doctor's diagnosis and treatment of patients.
    The United States Zhirui Consulting (DDI) certification consultant lecturer Zhang Wei also believes: this adjustment has long been there, but the implementation of the local far, a little at any time to adjust the elastic meaning, but in general, the representatives of the new region may have a relatively large impact, the relative stability of the relationship between the old representatives is not too big.
    prohibit medical representatives from visiting doctors in outpatient areas, which would have a slight impact on the way medical representatives transmit academic information.
    Sun Yuewu suggested: Now many enterprises in a way, such as the doctor to come out to do academic activities, academic exchanges, on the other hand, through digital tools, through online academic exchanges to achieve the role of doctors to convey information on drug diagnosis and treatment.
    he further explained that while medical representatives have performance appraisal requirements, such as how many doctors must visit each day to convey information about drug treatment, there is no restriction on specific occasions.
    for example, a doctor's week's work, a few days is an outpatient, a few days in the ward, the remaining days in another workplace, then in addition to the clinic time, it is possible to communicate with the doctor academically.
    ", but offline communication, face-to-face communication is very important, only two people face-to-face, in order to solve some of the doctor's personal confusion and problems.
    " Sun Yuewu stressed, so the offline visit is still very important, first of all to ensure that we are purely academic, no gold behavior, and second, flexible treatment, if not in the hospital, can be replaced by other forms.
    the filing system, how to implement the "Notice" issued by the National Health and Care Commission, the medical representatives to the medical personnel illegal marketing to form a restriction, then the medical representative filing system or a good solution.
    it is true that this year, the most influential document for medical representatives is the "Measures for the Administration of the Record of Medical Representatives (Trial) (Draft for Comments)" issued on June 5, which provides for the academic promotion of medical representatives.
    the Measures, medical representatives may carry out academic promotion and other activities in the following forms: (1) communicating with medical personnel in person with medical institutions; (2) holding academic conferences and lectures; (3) providing academic materials; (4) communicating via the Internet or teleconference; and (5) other forms of medical institutions agreeing to.
    even "in-person communication with medical personnel in medical institutions", must also be approved by medical institutions, with the "Pharmaceutical Representative Filing Management Measures" gradually landing, major medical institutions may publish the filing system and academic promotion of the corresponding rules.
    in addition, the Measures clearly stipulate that sales tasks shall not be undertaken, collection and handling of purchase and sale bills.
    but for the time being, it is foreseeable that the document will still need time and process from implementation to gradual landing.
    the above-mentioned professionals said that the current sales indicators are still difficult to cancel, because the cancellation of sales indicators, the team can not manage.
    or more from its performance appraisal point of view, improve the efficiency of work, to prevent gold behavior.
    to some extent, the state has given enterprises a direction: to diversify the assessment indicators, no longer only sales theory, intended to promote the academic promotion of medical representatives through multi-dimensional indicators, such as the provision of medical representatives to master academic information and academic knowledge, and the frequency of academic exchanges with doctors.
    Sun Yuewu believes that there are three levels to promote the compliance of pharmaceutical marketing.
    first, the national level constantly issued relevant regulations to restrain the marketing behavior of enterprises, such as the filing system, the second is the enterprise level, through the improvement of their own system and the revision of performance indicators to strictly manage sales staff, agents' marketing activities, and the third is that pharmaceutical representatives should consciously enhance their professional sales ability, to the direction of academic transformation.
    Zhang Wei also believes that, in the long run, the filing system and the relative reduction of clinical extension personnel on the overall health and safety of the public still have some benefits.
    by guiding the medical representatives to transform academic promotion, downplaying the past only focus on results, short and smooth profit-making model, return to the direction of passing professional information to doctors, representatives can be used as clinical pharmacy and clinical medicine to cooperate to promote drug safety.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.